SBF2 and hepatocellular carcinoma: Functional loss experiments observed that si-SBF2-AS1 markedly reduced the expression of N-cadherin and vimentin, but slightly restored the expression of E-cadherin, thereby attenuating the invasiveness and metastasis of HCC cells [56].